Jonathan P. Mow

Overview

Jonathan P. Mow received an average of $1M in total compensation, including $445K in salary, at PhaseBio Pharmaceuticals from 2017 to 2021.

Source: SEC filings on April 22, 2022, April 24, 2020, and April 5, 2019.

Related executives

We found three more executives who work or worked at PhaseBio Pharmaceuticals.

John Lee

PhaseBio Pharmaceuticals

Chief Medical Officer

John Sharp

PhaseBio Pharmaceuticals

Chief Financial Officer

John Sharp

PhaseBio Pharmaceuticals

Chief Financial Officer

News

You may also like